نتایج جستجو برای: aml m7

تعداد نتایج: 13547  

Journal: :Blood 1992
S A Betz K Foucar D R Head I M Chen C L Willman

Because neither morphologic nor routine cytochemical features are pathognomonic, the diagnosis of acute megakaryoblastic leukemia (AML-M7) is difficult, requiring either specialized ultrastructural or immunologic techniques. Because the ultrastructural techniques are cumbersome, immunologic assays for expression of several platelet-specific antigens, such as CD41a (platelet glycoprotein IIb/III...

Journal: :Blood 2005
Laurent Garderet Myriam Labopin Norbert-Claude Gorin Emmanuelle Polge André Baruchel Giovanna Meloni Juan Ortega Jaak Vossen Donald Bunjes Guy Leverger Didier Blaise Augustin Ferrant Mats Brune Eric Dore Helmut Gadner Felix Zintl Isaac Yaniv Giorgio Dini Francesco Frassoni

Acute megakaryoblastic leukemia (M7 AML) is a highly aggressive disease. We evaluated outcomes in 57 children (11 with Down syndrome) and 69 adults with M7 AML after first complete remission (CR1) following autologous or HLA-identical allogeneic transplantation. Characteristics of the recipients of autologous transplants (38 children, 37 adults) were, respectively: median age, 1.7 and 46 years;...

Journal: :Haematologica 2008
Rebecca James Tracy Lightfoot Jill Simpson Anthony V Moorman Eve Roman Sally Kinsey

The association between Down’s syndrome (DS) and acute leukemia is well documented. However, most information derives from retrospectively compiled patient series or treatment trials, which may not represent the general DS population. We report cases of acute leukemia and DS collected in the UK Childhood Cancer Study (UKCCS), a national population based case-control study. Data were gathered on...

2014
R Masoumi-Dehshiri AS Hashemi H Neamatzadeh H Zare-Zardeini

Acute myeloid leukemia (AML-M7) is a type of pediatric AML accounting for 3-10% of primary childhood AML and children may present with a broad variety of symptoms including low-grade fever, diarrhea, easy bruising, failure to gain weight and life-threatening conditions. We report a rare case of AML .A 26-month-old boy who presented with weakness and fatigue. He was diagnosed as a case of AMLM-7...

Journal: :iranian journal of pediatric hematology and oncology 0
r masoumi-dehshiri nutrition and food security research centre, shahid sadoughi university of medical sciences, yazd, iran as hashemi hematology and oncology research center, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences) h neamatzadeh hematology and oncology research center, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences) h zare-zardini hematology and oncology research center, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences)

acute myeloid leukemia (aml-m7) is a type of pediatric aml accounting for 3–10% of primary childhood aml and children may present with a broad variety of symptoms including low-grade fever, diarrhea, easy bruising, failure to gain weight and life-threatening conditions. we report a rare case of aml .a 26-month-old boy who presented with weakness and fatigue. he was diagnosed as a case of amlm-7...

Journal: :The Gulf journal of oncology 2014
M A Obaid M Bourusly P Ancliff E Al Matter

We report an 18-months old boy with trisomy 21 who initially presented with myelodysplastic syndrome MDS, and later transformed into acute megakaryoblastic leukaemia AML. At presentation he was found to have some unusual findings namely multiple soft tissue masses over scalp, left elbow and over the knee joints as well as hard mass felt in left hip. Biopsy of soft tissue of scalp revealed granu...

2010
Arie Franco Kristopher N. Lewis Joshua M. Blackmon Elizabeth J. Manaloor

Acute myeloid leukemia (AML) is also referred to non-lymphocytic leukemia in the literature. It comprises about 15% of the childhood leukemia. There are multiple subtypes of AML from M0-M7 with approximately 45% of the cases being M0-M2 and the remaining subtypes being rare. The definitive diagnosis relies on bone marrow biopsy showing bone marrow infiltration with leukemic cells. We describe a...

Journal: :Blood 2009
Omar Abdel-Wahab Ann Mullally Cyrus Hedvat Guillermo Garcia-Manero Jay Patel Martha Wadleigh Sebastien Malinge JinJuan Yao Outi Kilpivaara Rukhmi Bhat Kety Huberman Sabrena Thomas Igor Dolgalev Adriana Heguy Elisabeth Paietta Michelle M Le Beau Miloslav Beran Martin S Tallman Benjamin L Ebert Hagop M Kantarjian Richard M Stone D Gary Gilliland John D Crispino Ross L Levine

Disease alleles that activate signal transduction are common in myeloid malignancies; however, there are additional unidentified mutations that contribute to myeloid transformation. Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leuk...

Journal: :Blood 2008
Zhifu Xiang Yu Zhao Vesselin Mitaksov Daved H Fremont Yumi Kasai AnnaLynn Molitoris Rhonda E Ries Tracie L Miner Michael D McLellan John F DiPersio Daniel C Link Jacqueline E Payton Timothy A Graubert Mark Watson William Shannon Sharon E Heath Rakesh Nagarajan Elaine R Mardis Richard K Wilson Timothy J Ley Michael H Tomasson

Somatic mutations in JAK2 are frequently found in myeloproliferative diseases, and gain-of-function JAK3 alleles have been identified in M7 acute myeloid leukemia (AML), but a role for JAK1 in AML has not been described. We screened the entire coding region of JAK1 by total exonic resequencing of bone marrow DNA samples from 94 patients with de novo AML. We identified 2 novel somatic mutations ...

2003
Y. Ravindranath E. Abella J. P. Krischer J. Wiley Inoue M. Harris A. Chauvenet C. S. Alvarado R. Dubowy A. K. Ritchey V. Land C. P. Steuber H. Weinstein

The treatment of acute myeloid leukemia (AML) in children with Down's syndrome (DS) has engendered considerable controversy. Because of the concerns for toxicity and increased rate of infections, treatment approaches varied considerably in the past with mixed results. However, experience on the recently completed Pediatric Oncology Group (POG) 8498 AMI. study suggests that DS children with AML ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید